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Outcomes*
Number of Studies
(Number of Subjects)
Risk Ratio
(95% CI) I2, %
Excellent intubating conditions 50 (4,151) 0.86 (0.81–0.92) 72
Clinically acceptable conditions
(excellent or good)
48 (3,992) 0.97 (0.95–0.99) 68
Subgroup analysis
Emergency intubations: excellent
intubation conditions
5 (1,073) 0.84 (0.73–0.98) 53
Pediatric: excellent intubation conditions 5 (536) 0.86 (0.70–1.06) 81
CI, Conﬁdence interval.
*Goldberg scale for intubating conditions: excellent, good, poor, and inadequate. Scale assesses the ease of
intubation, vocal cord movement, and patient response to intubation (ie, cough, diaphragm movement). “Excellent”
indicates ease of intubation with immobile open vocal cords and no patient movement.Of the 66 identiﬁed studies, 50 met
inclusion criteria for analysis,
comprising 4,151 patients. Main
outcomes and selected subgroup
analysis are summarized in the
Table. The overall evidence was
deemed moderate quality because
of a high incidence of detection bias
(ie, 50% of the intubators were not
blinded to the fasciculations caused
by succinylcholine), and there was
substantial heterogeneity among
the trials, which could not be
explained by subgroup analysis.
Although subgroup analysis oflished in final edited form as:
es Rocuronium Create Better Intubating Co
cy Medicine, 5(69), e55-e56. https://doi.org/emergency intubations determined
that succinylcholine is superior to
rocuronium in achieving excellent
intubating conditions, there was no
difference between the 2 drugs in
terms of clinically acceptable intu-
bating conditions. In the pediatric
subgroup analysis, there was no
difference between rocuronium
and succinylcholine; however, the
sample size was small and substan-
tial heterogeneity was identiﬁed.
None of the trials in this systematic
review reported severe adverse
outcomes.Annals of Emergency Medicine e1
nditions Than Succinylcholine for 
10.1016/j.annemergmed.2016.09.001
Systematic Review SnapshotCommentary
Selecting the ideal paralytic for
rapid sequence intubation is often
challenging, and there may be spe-
ciﬁc cases in which one paralytic is
preferred over another; however,
identifying one agent that overall
creates more ideal intubating con-
ditions is important. In this updated
systematic review, succinylcholine
was determined to be superior to
rocuronium for producing excel-
lent intubating conditions overall
and also in the subgroup of emer-
gency intubations.
The ongoing debate about succinyl-
choline and rocuroniummustweigh
the risks and beneﬁts of each para-
lytic. Thebeneﬁts of succinylcholine
include a rapid onset (50 seconds)
and a short duration of action (7 to
11 minutes).1 Because succinylcho-
line is a depolarizing neuromuscular
blocker, there is a risk of malignant
hyperthermia- and hyperkalemia-
induced cardiac arrhythmias in
patients with “denervation syn-
dromes” (eg, amyotrophic lateral
sclerosis,multiple sclerosis, Guillain-
Barré) and in patients who began
“denervation states” 48 to 72 hours
earlier, including spinal cord
injuries, major burns, and crush in-
juries.2 A recent study found that,
compared with rocuronium, succi-
nylcholine was associated with
increased mortality in emergency
department patients with severe
traumatic brain injury who under-
went rapid sequence intubation.3
The beneﬁts of rocuronium include
a rapid onset (55 to 90 seconds)
and no known contraindications.1
However, because rocuronium is a
nondepolarizing blocker and it has
an intermediate duration of action
(37 to 73 minutes), it may be lesse2 Annals of Emergency Medicinedesirable under certain clinical
situations.1 Prolonged paralysis can
be problematic for patients with a
difﬁcult airway, with unstable vital
signs, or requiring frequent neuro-
logic checks.
The dosing of rocuronium is an
important covariate because it may
have an effect on intubating con-
ditions. In subgroup analysis,
although succinylcholine was su-
perior to rocuronium at doses of
0.6 to 0.7 mg/kg, there was no dif-
ference at doses of 0.9 to 1.0mg/kg
or 1.2 mg/kg. Although the small
sample size of the higher doses
prevented drawing a conclusion,
Patanwala et al4 found equivalency
between succinylcholine and
rocuronium at these higher doses.
Recent reports suggest that trends
in paralytic choice are evolving
among emergency physicians. A
multicenter prospective registry
collected data on 17,583 adult
emergency intubations from 2002
to 2012.5 Although data indicated
succinylcholine was used in 75%
of rapid sequence intubations, its
use decreased sharply during the
10 years. In contrast, rocuronium
use increased from 8.2% (2002 to
2005) to 42% (2009 to 2012),
suggesting that physicians are
becoming more familiar and
comfortable with rocuronium.5
Additional outcomes of interest in
rapid sequence intubation have
been studied and further suggest
equivalencybetween the2paralytic
agents. Marsch et al6 found no dif-
ference between succinylcholine
and rocuronium in terms of oxygen
desaturation, intubating conditions,
or failed intubation attempts.
Patanwala et al4 also reported
no difference in ﬁrst-attemptintubation success between succi-
nylcholine and rocuronium at a
median dose of 1.19 mg/kg.
Although succinylcholine remains
superior to rocuronium as the ﬁrst-
line agent in maximizing intubat-
ing conditions, rocuronium is a
suitable alternative in emergency
intubations when succinylcholine
poses a risk.
Editor’s Note: This is a clinical
synopsis, a regular feature of the
Annals’ Systematic Review Snapshots
(SRS) series. The source for this
systematic review snapshot is: Tran
DT, Newton EK, Mount VA, et al.
Rocuronium versus
succinylcholine for rapid
sequence induction intubation.
Cochrane Database Syst Rev.
2015;(10):CD002788. http://dx.
doi.org/10.1002/14651858.
CD002788.pub3.
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